Immunogen Inc Revenue per Employee (IMGN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Immunogen inc   (NASDAQ: IMGN)
 

Immunogen Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 637.72% in the third quarter 2023, year on year to cumulative value of $288 million, Immunogen Inc 's revenue per employee grew on a trailing twelve months basis to $ 831,254. The productivity of Immunogen Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 12 other companies have achieved higher revenue per employee. While Immunogen Inc 's total ranking has deteriorated compared to the previous quarter from 158 to 209. Immunogen Inc has 346 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IMGN Revenue per Employee (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Revenue Change 637.72 % 487.16 % 30.97 % 47.07 % 66.94 %
Sales per Employee (TTM) $ 831,254 547,873 348,477 314,399 276,321
IMGN's Total Ranking # 209 # 158 # 976 # 1027 # 0
Seq. Revenue Change 36.41 % 66.74 % 21.14 % 167.75 % 8.57 %

IMGN Company Profile >> Back to IMGN Efficiency Comparisons >> Compare IMGN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 13
Overall Market # 209

Revenue per Employee Statistics
High Average Low
$ 1,438,070 $ 434,343 $ 220,150
(Sep 30 2023)   (Mar 31 2019)



Financial Statements
Immunogen Inc 's Revenue MRQ $ 113 Millions Visit IMGN's Income Statement
Immunogen Inc 's Revenues TTM $ 288 Millions Visit IMGN's aggregate revenue growth
What are IMGN's Sales? Visit IMGN's Sales by Segment




Other Ratios
Immunogen Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
IMGN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for IMGN's Competitors
Revenue per Employee for IMGN's Suppliers
Revenue per Employee for IMGN's Customers

You may also want to know
IMGN's Sales Growth Rates IMGN's Pe Price to earnings ratio IMGN's Receivables Turnover Ratio IMGN's Stock Quote
IMGN's Net Income Growth Rates IMGN's Ps Price to Sales ratio IMGN's Sales per Employee IMGN's Asset Turnover Ratio
IMGN's Net Margin IMGN's Pb Price to Book ratio IMGN's Financial Strength Ratios IMGN's Dividend Payout Ratio
Date modified: 2026-08-29T17:15:19+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2023Number of Employees Sep 30 2023
Paragon 28 inc   1,437,097.22 $ 206.942  Million 144 
Coherus Oncology inc   1,435,863.95 $ 211.072  Million 147 
Sangamo Therapeutics Inc   1,418,450.70 $ 201.420  Million 142 
Keenova Therapeutics Plc  1,416,312.50 $ 2,266.100  Million 1,600 
G1 Therapeutics Inc   1,416,145.45 $ 77.888  Million 55 
Novavax inc   1,401,551.40 $ 1,049.762  Million 749 
Nektar Therapeutics  1,400,952.38 $ 88.260  Million 63 
Bristol myers Squibb Company  1,382,615.38 $ 44,935.000  Million 32,500 
Journey Medical Corp  1,377,413.79 $ 79.890  Million 58 
Adc Therapeutics Sa  1,361,015.54 $ 262.676  Million 193 
Biogen Inc   1,332,440.00 $ 9,993.300  Million 7,500 
Scilex Holding Company  1,329,411.76 $ 45.200  Million 34 
Sarepta Therapeutics Inc   1,323,331.74 $ 1,104.982  Million 835 
Jazz Pharmaceuticals Plc  1,312,938.41 $ 3,794.392  Million 2,890 
Dynavax Technologies Corporation  1,309,745.45 $ 360.180  Million 275 
Privia Health Group Inc   1,289,831.16 $ 1,581.333  Million 1,226 
Collegium Pharmaceutical Inc   1,289,654.85 $ 545.524  Million 423 
Puma Biotechnology Inc   1,280,078.21 $ 229.134  Million 179 
Incyte Corporation  1,268,990.15 $ 3,609.008  Million 2,844 
Agenus Inc  1,245,641.98 $ 100.897  Million 81 
Harpoon Therapeutics Inc   1,244,700.00 $ 37.341  Million 30 
Aurinia Pharmaceuticals Inc   1,241,039.06 $ 158.853  Million 128 
Alpine Immune Sciences Inc   1,231,960.00 $ 30.799  Million 25 
Emergent Biosolutions Inc   1,226,333.33 $ 1,103.700  Million 900 
Progyny Inc   1,205,584.11 $ 1,031.980  Million 856 
Xenetic Biosciences Inc   1,177,497.50 $ 2.355  Million 2 
Arbutus Biopharma Corp  1,170,578.95 $ 22.241  Million 19 
Cano Health Inc   1,148,854.07 $ 3,101.906  Million 2,700 
Voyager Therapeutics Inc   1,123,390.07 $ 158.398  Million 141 
Carisma Therapeutics Inc   1,100,652.17 $ 50.630  Million 46 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.